Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Related Concept Videos

Atherosclerosis II: Clinical Manifestations and Diagnostic Tests

Atherosclerosis II: Clinical Manifestations and Diagnostic Tests

Atherosclerosis is a progressive disorder that leads to the thickening and narrowing of arterial walls due to plaque buildup. This condition can cause various symptoms depending on the arteries affected:Coronary Artery Disease (CAD): This condition affects the coronary arteries and may lead to chest pain (angina), shortness of breath (dyspnea), heart attacks, and other heart disease symptoms.Cerebrovascular Disease: This affects blood flow to the brain, causing transient ischemic attacks (TIAs)...

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by

Same author

Hypogammaglobulinaemia in patients with ANCA-associated vasculitis treated with rituximab.

Frontiers in medicine·2026

Same author

Adverse Muscle Composition Is Associated with All-Cause Mortality in CKD: A UK Biobank Imaging Study.

Clinical journal of the American Society of Nephrology : CJASN·2026

Same author

Neutrophil:lymphocyte ratio and cell-free DNA dynamics during excessive heat stress in occupational and experimental settings.

Journal of thermal biology·2026

Same author

Incidence and prevalence of autoimmune disease in the Swedish National Patient Register.

European journal of epidemiology·2026

Same author

Nuclear cell-free DNA on the loose: an early warning signal of ischemia-reperfusion injury in kidney transplantation.

Frontiers in immunology·2026

Same author

Complement activation in anti-glomerular basement membrane disease before and after treatment with imlifidase.

Clinical kidney journal·2026

Same journal

Vaccination coverage of influenza and pneumococcal vaccines in patients with rheumatic diseases: a systematic review and meta-analysis.

Rheumatology (Oxford, England)·2026

Same journal

Comment on: Distinct cytokine and cytokine receptor expression patterns characterise different forms of myositis.

Rheumatology (Oxford, England)·2026

Same journal

A Delphi survey of patients and clinicians on a unified and stratified approach to managing GCA-PMR spectrum disease.

Rheumatology (Oxford, England)·2026

Same journal

Cardiac involvement in Behçet's syndrome: findings from a clinically driven cardiological evaluation.

Rheumatology (Oxford, England)·2026

Same journal

Mechanisms, clinical manifestations and management of cardiovascular diseases in ANCA-associated vasculitis.

Rheumatology (Oxford, England)·2026

Same journal

Clinical and autoantibody associations with malignancy in systemic sclerosis: A systematic review and meta-analysis.

Rheumatology (Oxford, England)·2026

See all related articles

Search research articles

Related Experiment Video

Updated: Dec 23, 2025

Reliable Isolation of Central Nervous System Microvessels Across Five Vertebrate Groups

Reliable Isolation of Central Nervous System Microvessels Across Five Vertebrate Groups

Published on: January 12, 2020

Serological testing in small vessel vasculitis.

Mårten Segelmark¹

¹Department of Clinical Sciences, Nephrology, Skane University Hospital, Lund University, Lund, Sweden.

Rheumatology (Oxford, England)

|April 30, 2020

Summary

This summary is machine-generated.

Serological tests, including anti-neutrophil cytoplasmic antibodies (ANCA), are crucial for diagnosing small vessel vasculitis and monitoring treatment. Autoantibodies aid in identifying primary and secondary vasculitis, with ANCA being key for ANCA-associated vasculitis.

Keywords:

ANCA autoantibodies complement cryoglobulins vasculitis

More Related Videos

Author Spotlight: Expanding the Scope of Multiplex Immunoassays for Lyme Borreliosis Diagnostics and Pathogen Research

Author Spotlight: Expanding the Scope of Multiplex Immunoassays for Lyme Borreliosis Diagnostics and Pathogen Research

Published on: July 14, 2023

Isolating and Using Sections of Bovine Mesenteric Artery and Vein as a Bioassay to Test for Vasoactivity in the Small Intestine

Isolating and Using Sections of Bovine Mesenteric Artery and Vein as a Bioassay to Test for Vasoactivity in the Small Intestine

Published on: October 7, 2014

Related Experiment Videos

Last Updated: Dec 23, 2025

Reliable Isolation of Central Nervous System Microvessels Across Five Vertebrate Groups

Reliable Isolation of Central Nervous System Microvessels Across Five Vertebrate Groups

Published on: January 12, 2020

Author Spotlight: Expanding the Scope of Multiplex Immunoassays for Lyme Borreliosis Diagnostics and Pathogen Research

Author Spotlight: Expanding the Scope of Multiplex Immunoassays for Lyme Borreliosis Diagnostics and Pathogen Research

Published on: July 14, 2023

Isolating and Using Sections of Bovine Mesenteric Artery and Vein as a Bioassay to Test for Vasoactivity in the Small Intestine

Isolating and Using Sections of Bovine Mesenteric Artery and Vein as a Bioassay to Test for Vasoactivity in the Small Intestine

Published on: October 7, 2014

Area of Science:

Rheumatology
Immunology
Internal Medicine

Background:

Serological analysis is integral to diagnosing and managing small vessel vasculitis (SVV).
Autoantibodies are present in primary and secondary forms of SVV.
Anti-neutrophil cytoplasmic antibodies (ANCA) are vital biomarkers for pauci-immune SVV, also known as ANCA-associated vasculitis (AAV).

Purpose of the Study:

To highlight the significance of serological tests in the diagnosis and monitoring of small vessel vasculitis.
To review key autoantibodies associated with primary and secondary SVV.
To discuss the role of ANCA and other autoantibodies in specific vasculitic conditions.

Main Methods:

Review of serological diagnostic markers for small vessel vasculitis.
Analysis of autoantibody prevalence in different vasculitis subtypes.
Discussion of the clinical utility of specific autoantibody testing.

Main Results:

ANCA are detected in 75-95% of patients with pauci-immune SVV.
Other significant autoantibodies include anti-GBM, anti-C1q, anti-galactose deficient IgA, and cryoglobulins.
Serological tests can identify SVV secondary to systemic diseases like SLE, rheumatoid arthritis, Hepatitis C, and HIV.

Conclusions:

Serological testing, particularly ANCA detection, is essential for diagnosing and managing small vessel vasculitis.
A range of autoantibodies aids in classifying and monitoring various forms of SVV.
Identifying associated systemic conditions through serology is critical for comprehensive patient care.